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Introduction: In 1975 Eloise Giblett discovered a child with a specific T-cell immunodeficiency and traced the biochemical defect to a genetic deficiency of PNP 1 (1) .
Subsequent investigations demonstrated that the biochemical link between PNP and T-cell deficiency was the failure to degrade deoxyguanosine and its conversion to dGTP in activated Tcells (2, 3) . Stimulated T-cells require DNA synthesis for cell division, and excess dGTP acts to allosterically inhibit ribonucleotide diphosphate reductase causing unbalanced deoxynucleotide pools and the induction of apoptosis (4, 5) . Dividing T-cells induce deoxycytidine kinase activity relative to resting T-cells and this enzyme also accepts deoxyguanosine when blood levels are elevated (6) . Under normal conditions the blood level of deoxyguanosine is less than 0.1 µM because of high levels of PNP in human erythrocytes and in liver, spleen and intestine (7) . In PNP-deficient patients the deoxyguanosine level in blood can reach 10 µM, causing its accumulation as dGTP in stimulated T-cells.
Structure-based inhibitor design using early X-ray crystal structures of human PNP led to a family of inhibitors with dissociation constants to 15 nM, but these were insufficient to cause the sustained elevation of blood deoxyguanosine needed to suppress division of activated T-cell populations (9) . Transition state analogue inhibitor design based on the transition state structure of bovine PNP led to the design and synthesis of ImmH 1 , a 23 pM inhibitor for the bovine 4 recently gained Immucillin-H approval to enter phase I/II clinical trials against T-cell leukemia (14) .
Recently, we have examined the transition state structure of human PNP 2 , since it and the bovine PNP are known to have different binding affinities with the Immucillin transition state analogues (11, 15) . When a transition state analogue binds with different strengths to isozymes such as the human and bovine PNPs, a difference in their transition state structures is likely to be the cause. Despite an 87% amino acid identity between human and bovine PNPs, differences at the homotrimeric subunit interfaces cause differences in catalytic site cooperativity and apparently, differences in transition state properties (11) . Kinetic isotope effect analysis 2 established that the transition state is more dissociated for the human enzyme, with greater separation between the ribosyl group and the departing purine ring. While Immucillin-H is wellsuited to the transition state of bovine PNP, DADMe-Immucillin-H is better matched to the more dissociated transition state ( Figure 1 ). Here we demonstrate that the DADMe-Immucillins are more powerful inhibitors of human PNP than the first-generation Immucillins designed to match the transition state of bovine PNP. The oral availability of DADMe-Immucillin-H is established in a mouse model and its biological efficiency is compared to Immucillin-H. DADMeImmucillin-H is a sufficiently powerful inhibitor of PNP in circulating mouse erythrocytes that regain of blood PNP activity occurs primarily by synthesis of new erythrocytes.
Experimental Procedures
Human PNP. The plasmid (pEPD) containing human PNP sequence was the generous gift of Scott McIvor, M.D. (16) . Polymerase chain reaction with designed primers purchased from Invitrogen was performed to amplify PNP DNA which was cloned to T7/NT TOPO vector and transformed in BL21(DE3) E.Coli strain. In the coupled assay hypoxanthine formed by phosphorolysis of inosine was oxidized to uric acid and followed spectrophotometrically at 293 nm (extinction coefficient for uric acid ε 293 = 12.9 mM -1 ) (21). The dissociation constant for slow-onset tight-binding inhibitors was determined from reaction rates after slow onset inhibition had occurred according to the equation
, where υ is the steady state reaction rate after the slow-onset inhibition period has reached equilibrium, k cat is the rate at substrate saturation, S is substrate concentration, K m is the Michaelis constant for inosine (38 µM under these conditions), I is inhibitor concentration and K d is the equilibrium dissociation constant for the tightly-inhibited PNP-inhibitor complex (22) . For inhibitors without slow-onset properties, fits to the same equation were made, but using initial reaction rates. 
Rate constants for dissociation of PNP•Immucillin•PO 4 -Inhibition of PNP by the
Immucillins is a two step process to form the tightly-bound complex of PNP (11) . The rate of inhibitor release was estimated by the regain of enzyme activity following dilution of stoichiometric complexes formed by prolonged incubation similar to experiments described earlier for Immucillin-H and Immucillin-G with bovine PNP (11) . Briefly, human PNP (96 µM, inhibitors (105 to 108 µM and PO 4 (50 mM pH 7.5) were incubated at 25 o C for 5.5 hr to assure equilibrium. Mixtures were diluted 1:500,000 by a 1:500 dilution into 20 mM Tris-HCl pH 7.5 followed immediately by a 1:1000 dilution into assay mixtures containing 1 mM inosine as described above. The rate constant for dissociation of inhibitors was calculated from fits to the initial regain of catalytic activity as described earlier (11) . These experiments also demonstrate the reversible inhibition caused by Immucillins. µL of the lysate was added to 735 µL complete reaction mixture containing 1 mM inosine, 50 mM phosphate, pH = 7.4 and 60 mU/ml xanthine oxidase. After mixing, the reaction progress was followed spectrophotometrically at 293 nm. For determination of the equilibrium dissociation constant (K d ) the slope was taken after the slow-onset steady-state inhibition had 7 occurred (typically 40-50 min under conditions of Figure 3 ). In separate experiments, samples of tail blood (5 µL) were pipetted into 1 mL ice-cold PBS, centrifuged in the cold, resuspended in a second 1 mL sample of fresh PBS, and the pellet of washed erythrocytes finally lysed in 5 µL of PBS containing Triton X-100 and assayed as above.
Oral availability of ImmH and DADMe-ImmH-

RESULTS AND DISCUSSION
Inhibition of PNP by Immucillins-Human PNP was inhibited by ImmG, ImmH and 8-aza-ImmH to give equilibrium dissociation constants (K d ) of 42, 56 and 180 pM (see Figure 1 ).
The kinetic properties exhibited slow-onset, tight binding inhibition typical of inhibition by compounds that resemble transition state analogues (22) . The Immucillins were designed to match the transition state for bovine PNP, which has a C1'-N9 ribosidic bond of 1.77 Å at the transition state (Figure 2 ; 10). The Immucillin transition state analogues are found to be better inhibitors of the bovine enzyme than the human PNP (to 23 pM for the bovine enzyme; 11), establishing that the transition states of the two enzymes differ, despite 87% amino acid sequence identity and the observation that every amino acid at the catalytic site is conserved (23) . Tight-binding of the Immucillins to bovine PNP depends on two essential features (24).
The 9-deazahypoxanthine structure increases the pK a at N7 to above 10, and the N7 of substrate at the transition state is known to be a proton acceptor. The 4'-N in the iminoribitol has a pK a of 6.9 in ImmH and is protonated at the catalytic site to resemble the cationic feature of substrates at the transition state (25) . Loss of either of these features destroys the tight binding to PNP (24) .
Design principles of the DADMe-Immucillins-Recent kinetic isotope effect studies with human PNP have established that the transition state structure differs from that of the bovine enzyme, to give a C1'-N9 ribosidic bond length of greater than 2.5 Å and weak participation of the anionic nucleophile (>3.0 Å for arsenate). These features cause increased cation character at 8 C1' compared to the transition state for bovine PNP (Figure 2) 2 . The Immucillins have a covalent C-C bond between the iminoribitol and the 9-deazapurine group and this bond length is near 1.5 Å, making it at least 1.0 Å shorter than the corresponding atoms at the transition state.
In more dissociated transition states like that of the human PNP, the cationic charge on the ribooxacarbenium ion becomes more highly developed and centered at the C1' carbocation, rather than being distributed over O4', C1' and N9 when the transition state has significant residual bond order remaining between C1' and N9 (26) . We proposed that spacing the ImmH binds with a dissociation constant of 2.0 nM, and does not exhibit slow-onset inhibition.
The affinity of 8-substituted ImmH analogues with the bovine PNP have shown that the pK a at N7 is an important parameter for Immucillin binding (24) . The carbonyl oxygen of Asn243 forms a short H-bond to the N7 proton of ImmH (28) . Loss of binding energy in 8-aza-DADMeImmH relative to 8-aza-ImmH reveals that either the pK a or the contact geometry between N7
and Asn243 is not as favorable as it is in 8-aza-DADMe-ImmH.
The kinetics of DADMe-ImmH inhibition of human PNP demonstrate two distinct inhibitory phases (Figure 3 ). In the first few minutes, the initial rate slopes change rapidly to reach a second steady-state plateau of increased inhibition. This is characteristic of transition state analogue inhibitors and reflects a slow enzymatic conformational change to form the tightly bound complex: E + I EI E*I, where E is free enzyme, I is inhibitor, EI is the rapidly- Thus, both ImmH and DADMe-ImmH are readily available from the gastrointestinal system and equilibrate with whole blood PNP more rapidly than they can be removed by hepatic or renal systems. Continued monitoring for the regain of enzymatic activity demonstrated that 50% of PNP in the blood regained activity at 100 hr (4.2 days) with ImmH ( Figure 4 ). In contrast, blood PNP regained activity more slowly with DADMe-ImmH, for a 50% activity regain at 275 hr, or 11.5 days.
At long times for regain of erythrocyte PNP activity, factors other than inhibitor release and metabolism must be considered. The average life-span for mouse erythrocytes is 25 days 
Comparison of off-rates and biological dissociation rates-The biological half-life of
DADMe-ImmH in the mouse results from the competition between binding to erythrocyte PNP and elimination from the animal. In the simplest case, the biological half-life would be directly related to the t 1/2 for the E*I complex. That is not the case for the Immucillins, with binding halflives of 8 to 120 min for ImmH, DADMe-ImmH and DADMe-ImmG respectively (Table 1) .
These are similar to the rates reported for other tight-binding inhibitiors of enzymes (Table 1 ). 
